New research into retatrutide, a dual agonist for GLP-1 and GIP receptors, are demonstrating promising outcomes in managing weight gain and diabetes second-type diabetes. Initial evidence suggest a novel action https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/